We are live on ! Find out more
BIMI

BIMI International Medical Inc. Common Stock

Delisted

BIMI was delisted on the 21st of August, 2024.

5 hedge funds and large institutions have $660K invested in BIMI International Medical Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

25% more funds holding

Funds holding: 45 (+1)

36% less capital invested

Capital invested by funds: $1.03M → $660K (-$373K)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BIMI Hedge Fund Activity: Q1 2019 in Review

5 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q1 2019, worth a combined $660K — down 36% from $1.03M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BIMI positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $168K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $1K sold.

  • 5 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q1 2019, up from 4 in Q4 2018.
  • Funds reported $660K of BIMI International Medical Inc. Common Stock stock for Q1 2019, down 36% quarter-over-quarter.
  • 2 funds opened new BIMI International Medical Inc. Common Stock positions in Q1 2019 and 1 closed out, a net change of +1 holder.
  • The largest BIMI International Medical Inc. Common Stock buyer in Q1 2019 was Morgan Stanley, an estimated $168K added.
  • The largest BIMI International Medical Inc. Common Stock seller in Q1 2019 was Tower Research Capital (TRC), an estimated $1K sold.

Based on aggregated 13F filings for Q1 2019.